Brad Sippy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brad Sippy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brad Sippy Today - Breaking & Trending Today

Will the Headache Field Embrace Rofecoxib (Vioxx)?

Published: July 7, 2022

Experts discuss the history of rofecoxib, including its market withdrawal and subsequent resurrection. The once-bestselling painkiller known as Vioxx is now proceeding to a phase 3 trial for migraine.

Source: medscape.com

Related Topics:

United StatesJoseph RossAlanm RapoportLos AngelesBrad SippyEli LillyYale UniversityUniversity Of CaliforniaDrug AdministrationJohn Arnold FoundationMedscape Professional NetworkInternational Headache SocietyTremeau PharmaceuticalsLocala HealthDevice Innovation ConsortiumDifferent MechanismNeurology ReviewsInternational HeadacheUnique RisksPrescribed DosesNew HavenCollegium PharmaceuticalMedical Device Innovation ConsortiumMedscape Professional